| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006 Oviedo, Spain
We have identified a human placenta cDNA coding for a new member of the matrix metalloproteinase (MMP) family. The isolated cDNA encodes a polypeptide of 261 amino acids, the smallest MMP identified to date, which contains several structural features of MMPs including the signal sequence, the prodomain involved in enzyme latency, and the catalytic domain with the zinc-binding site. However, it lacks the hinge region and hemopexin-domain present in most MMPs. According to these structural characteristics, the human MMP described herein has been called matrilysin-2 (MMP-26), because it exclusively shares with matrilysin this minimal domain organization required for secretion, latency, and activity. The amino acid sequence of matrilysin-2 also contains a threonine residue adjacent to the Zn-binding site that has been defined as a specific feature of matrilysin. Chromosomal location of the matrilysin-2 gene showed that it maps to the short arm of chromosome 11, a location distinct to that of other MMP genes. Matrilysin-2 was expressed in Escherichia coli, and, after purification and refolding, the recombinant protein was found to degrade synthetic substrates commonly used for assaying MMPs. Furthermore, this protein hydrolyzed type IV collagen, fibronectin, fibrinogen, and gelatin, which indicated that matrilysin-2 is a potent enzyme with a wide substrate specificity. In addition, it was found that matrilysin-2 is able to activate progelatinase B. Proteolytic activity of matrilysin-2 against all of these substrates was abolished by synthetic inhibitors and by tissue inhibitors of metalloproteinases. Expression analysis revealed that matrilysin-2 is detected not only in placenta and uterus but is widely expressed in malignant tumors from different sources as well as in diverse tumor cell lines. These data together with its broad spectrum of proteolytic activity, suggest that matrilysin-2 may play a role in some of the tissue-remodeling events associated with tumor progression.
This article has been cited by other articles:
![]() |
R. Pilka, I. Oborna, V. Lichnovsky, P. Havelka, H. Fingerova, P. Eriksson, S. Hansson, and B. Casslen Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients Hum. Reprod., December 1, 2006; 21(12): 3146 - 3156. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pilka, V. Noskova, H. Domanski, C. Andersson, S. Hansson, and B. Casslen Endometrial TIMP-4 mRNA is expressed in the stroma, while TIMP-4 protein accumulates in the epithelium and is released to the uterine fluid Mol. Hum. Reprod., August 1, 2006; 12(8): 497 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Savinov, A. G. Remacle, V. S. Golubkov, M. Krajewska, S. Kennedy, M. J. Duffy, D. V. Rozanov, S. Krajewski, and A. Y. Strongin Matrix Metalloproteinase 26 Proteolysis of the NH2-Terminal Domain of the Estrogen Receptor {beta} Correlates with the Survival of Breast Cancer Patients. Cancer Res., March 1, 2006; 66(5): 2716 - 2724. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qiu, S.-X. Bai, M.-r. Zhao, X.-q. Wu, Y.-G. Zhao, Q.-X. A. Sang, and Y.-L. Wang Spatio-Temporal Expression of Matrix Metalloproteinase-26 in Human Placental Trophoblasts and Fetal Red Cells During Normal Placentation Biol Reprod, April 1, 2005; 72(4): 954 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, A. Y. Savinov, D. V. Rozanov, V. S. Golubkov, H. Hedayat, T. I. Postnova, N. V. Golubkova, Y. Linli, S. Krajewski, and A. Y. Strongin Matrix Metalloproteinase-26 Is Associated with Estrogen-Dependent Malignancies and Targets {alpha}1-Antitrypsin Serpin Cancer Res., December 1, 2004; 64(23): 8657 - 8665. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, A. Vinitketkumnuen, Y. Adachi, H. Taniguchi, T. Hirata, N. Miyamoto, K. Nosho, A. Imsumran, M. Fujita, M. Hosokawa, et al. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma Carcinogenesis, December 1, 2004; 25(12): 2353 - 2360. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pilka, H. Domanski, S. Hansson, P. Eriksson, and B. Casslen Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26 Mol. Hum. Reprod., September 1, 2004; 10(9): 641 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Quesada, L. M. Sanchez, J. Alvarez, and C. Lopez-Otin Identification and Characterization of Human and Mouse Ovastacin: A NOVEL METALLOPROTEINASE SIMILAR TO HATCHING ENZYMES FROM ARTHROPODS, BIRDS, AMPHIBIANS, AND FISH J. Biol. Chem., June 18, 2004; 279(25): 26627 - 26634. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. S. Puente and C. Lopez-Otin A Genomic Analysis of Rat Proteases and Protease Inhibitors Genome Res., April 1, 2004; 14(4): 609 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Zhao, A.-Z. Xiao, H. I. Park, R. G. Newcomer, M. Yan, Y.-G. Man, S. C. Heffelfinger, and Q.-X. A. Sang Endometase/Matrilysin-2 in Human Breast Ductal Carcinoma in Situ and Its Inhibition by Tissue Inhibitors of Metalloproteinases-2 and -4: A Putative Role in the Initiation of Breast Cancer Invasion Cancer Res., January 15, 2004; 64(2): 590 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Park, Y. Jin, D. R. Hurst, C. A. Monroe, S. Lee, M. A. Schwartz, and Q.-X. A. Sang The Intermediate S1' Pocket of the Endometase/Matrilysin-2 Active Site Revealed by Enzyme Inhibition Kinetic Studies, Protein Sequence Analyses, and Homology Modeling J. Biol. Chem., December 19, 2003; 278(51): 51646 - 51653. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Goffin, C. Munaut, F. Frankenne, S. Perrier d'Hauterive, A. Beliard, V. Fridman, P. Nervo, A. Colige, and J.-M. Foidart Expression Pattern of Metalloproteinases and Tissue Inhibitors of Matrix-Metalloproteinases in Cycling Human Endometrium Biol Reprod, September 1, 2003; 69(3): 976 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Visse and H. Nagase Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry Circ. Res., May 2, 2003; 92(8): 827 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pilka, C. Whatling, H. Domanski, S. Hansson, P. Eriksson, and B. Casslen Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium Mol. Hum. Reprod., May 1, 2003; 9(5): 271 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Zhao, A.-Z. Xiao, R. G. Newcomer, H. I. Park, T. Kang, L. W. K. Chung, M. G. Swanson, H. E. Zhau, J. Kurhanewicz, and Q.-X. A. Sang Activation of Pro-gelatinase B by Endometase/Matrilysin-2 Promotes Invasion of Human Prostate Cancer Cells J. Biol. Chem., April 18, 2003; 278(17): 15056 - 15064. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-L. Li, S. A. Illman, H.-M. Wang, D.-L. Liu, J. Lohi, and C. Zhu Matrix metalloproteinase-28 transcript and protein are expressed in rhesus monkey placenta during early pregnancy Mol. Hum. Reprod., April 1, 2003; 9(4): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, H. Wang, Y. Zhao, H. Lin, Q. A. Sang, and C. Zhu Identification and specific expression of matrix metalloproteinase-26 in rhesus monkey endometrium during early pregnancy Mol. Hum. Reprod., October 1, 2002; 8(10): 934 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Park, B. E. Turk, F. E. Gerkema, L. C. Cantley, and Q.-X. A. Sang Peptide Substrate Specificities and Protein Cleavage Sites of Human Endometase/Matrilysin-2/Matrix Metalloproteinase-26 J. Biol. Chem., September 13, 2002; 277(38): 35168 - 35175. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, Y.-J. Cao, Y.-G. Zhao, Q.-X. A. Sang, and E.-K. Duan Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3 Mol. Hum. Reprod., July 1, 2002; 8(7): 659 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Llano, G. Adam, A. M. Pendas, V. Quesada, L. M. Sanchez, I. Santamaria, S. Noselli, and C. Lopez-Otin Structural and Enzymatic Characterization of Drosophila Dm2-MMP, a Membrane-bound Matrix Metalloproteinase with Tissue-specific Expression J. Biol. Chem., June 21, 2002; 277(26): 23321 - 23329. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Marchenko, G. N. Marchenko, and A. Y. Strongin Unconventional Activation Mechanisms of MMP-26, a Human Matrix Metalloproteinase with a Unique PHCGXXD Cysteine-switch Motif J. Biol. Chem., May 17, 2002; 277(21): 18967 - 18972. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujimoto, S. Parry, M. Urbanek, M. Sammel, G. Macones, H. Kuivaniemi, R. Romero, and J. F. Strauss III A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 (MMP-1) Promoter Influences Amnion Cell MMP-1 Expression and Risk for Preterm Premature Rupture of the Fetal Membranes J. Biol. Chem., February 15, 2002; 277(8): 6296 - 6302. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Nielsen, F. Rank, J. M. Lopez, M. Balbin, F. Vizoso, L. R. Lund, K. Dano, and C. Lopez-Otin Collagenase-3 Expression in Breast Myofibroblasts as a Molecular Marker of Transition of Ductal Carcinoma in Situ Lesions to Invasive Ductal Carcinomas Cancer Res., October 1, 2001; 61(19): 7091 - 7100. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Llano, A. M. Pendas, P. Aza-Blanc, T. B. Kornberg, and C. Lopez-Otin Dm1-MMP, a Matrix Metalloproteinase from Drosophila with a Potential Role in Extracellular Matrix Remodeling during Neural Development J. Biol. Chem., November 10, 2000; 275(46): 35978 - 35985. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Balbin, A. Fueyo, V. Knauper, J. M. Lopez, J. Alvarez, L. M. Sanchez, V. Quesada, J. Bordallo, G. Murphy, and C. Lopez-Otin Identification and Enzymatic Characterization of Two Diverging Murine Counterparts of Human Interstitial Collagenase (MMP-1) Expressed at Sites of Embryo Implantation J. Biol. Chem., March 23, 2001; 276(13): 10253 - 10262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J.G. Jimenez, M. Balbin, J. Alvarez, T. Komori, P. Bianco, K. Holmbeck, H. Birkedal-Hansen, J. M. Lopez, and C. Lopez-Otin A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation J. Cell Biol., December 24, 2001; 155(7): 1333 - 1344. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |